Eagle Pharmaceuticals, Inc.
EGRXDelisted Nov 26, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000827871
Eagle Pharmaceuticals, Inc. was delisted on Nov 26, 2024; its insiders filed their last Form 4 on Mar 1, 2024; 65 institutions reported holding it in 13F filings for Q3 2024, worth $31.9M in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Eagle Pharmaceuticals, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 126 | 108 | −18 |
| Shares | 10.8M | 10.3M | −477.6K (−4.4%) |
| Value | $209.5M | $162.9M | −$46.6M (−22.2%) |
New holders (13)
Institutions that held Eagle Pharmaceuticals, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Man Group plc | – | $577.2K | 0.00% |
| Kennedy Capital Management, Inc. | 36,486 | $575.4K | 0.01% |
| Tudor Investment Corp Et Al | 28,875 | $455.4K | 0.01% |
| Exchange Traded Concepts, LLC | 23,209 | $366.0K | 0.01% |
| Two Sigma Advisers, LP | 22,517 | $355.1K | 0.00% |
| PDT Partners, LLC | 19,745 | $311.4K | 0.04% |
| XTX Topco Ltd | 15,050 | $237.3K | 0.04% |
| Jacobs Levy Equity Management, Inc | 11,586 | $182.7K | 0.00% |
| Squarepoint Ops LLC | 10,885 | $171.7K | 0.00% |
| STRS Ohio | 9,200 | $145.0K | 0.00% |
| Point72 Middle East FZE | 4,974 | $78.4K | 0.00% |
| Comerica Bank | 626 | $9.87K | 0.00% |
| Simplex Trading, LLC | 230 | $3.00K | 0.00% |
Sold out (31)
Institutions that held Eagle Pharmaceuticals, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.